Clinical trial structures
- PMID: 21423788
- PMCID: PMC3059315
- DOI: 10.6030/1939-067x-3.1.8
Clinical trial structures
Abstract
Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is crucial. The selection of a clinical trial design structure requires logic and creativity. Common structural designs are discussed.
Figures
References
-
- Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy. Neurology. 2007;68:402–8. - PubMed
-
- Evans S, Testa M, Cooley T, Kwoen S, Paredes J, Von Roenn J. A Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi’s Sarcoma: An ACTG Clinical Study. Journal of Clinical Oncology. 2002;20:3236–41. - PubMed
-
- Evans S, Li L, Wei L. Data Monitoring in Clinical Trials Using Prediction. Drug Information Jounral. 2007a;41:733–42.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical